Venetoclax Basket Trial for High Risk Hematologic Malignancies

Clinical trial NCT05292664 · RECRUITING

Trial details

NCT number: NCT05292664
Sponsor: Andrew E. Place, MD
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Myelodysplastic Syndromes, de Novo Myelodysplastic Syndromes, Secondary Myelodysplastic Syndromes, Previously Treated Treatment-Related Acute Myeloid Leukemia Therapy-Related Myelodysplastic Syndrome Acute Lymphoblastic Leukemia, in Relapse Acute Lymphoblastic Leukemia With Failed Remission Lymphoblastic Lymphoma, in Relapse Lymphoblastic Lymphoma, Refractory Acute Leukemia of Ambiguous Lineage in Relapse Acute Leukemia of Ambiguous Lineage

Start date: 2023-03-29
Primary completion: 2028-07-02
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.